William McKee Net Worth & Insider Trades

William McKee - Chief Financial Officer, C4 Therapeutics, Inc

As of October 6, 2020

What is William McKee's Net Worth?

The current estimated net worth of C4 Therapeutics, Inc's Chief Financial Officer, William McKee, is estimated to be about $1.19M . William McKee owns about 5,263 units of C4 Therapeutics, Inc common stock. Recently at C4 Therapeutics, Inc, William McKee has sold an estimated value of $0 worth.

What is William McKee's Past Insider Trading?

William McKee's largest purchase order was 5,263 units , worth over $100K on October 6, 2020. In total, William McKee has made about 1 transaction recently at C4 Therapeutics, Inc. William McKee usually trades in October, with the busiest year in 2020.

WILLIAM MCKEE

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What was William McKee's Salary in 2020?

William McKee received compensation valued at about $2,099,745 in 2020 after becoming Chief Financial Officer. The vast majority of their compensation came in the form of option awards of $1,025,271 , other compensation of $1,074,474 .

C4 Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Andrew J. Hirsch 2020 $167,850 - $20,659,713 $98,800 $5,608 $20,931,971
Andrew J. Hirsch 2019 - - - - - -
Marc A. Cohen 2020 - - $9,063,399 - $69,500 $9,132,899
Marc A. Cohen 2019 - - - - - -
Andrew Phillips, Ph.D. 2020 $94,500 - - - $523,775 $618,275
Andrew Phillips, Ph.D. 2019 $520,000 - $3,377,316 $260,000 $36,359 $4,193,675
William T. McKee 2020 - - $1,025,271 - $1,074,474 $2,099,745
William T. McKee 2019 - - - - - -
Adam S. Crystal, M.D., Ph.D. 2020 $409,750 $61,000 $941,770 $184,800 $6,000 $1,603,320
Adam S. Crystal, M.D., Ph.D. 2019 $344,250 $100,000 $1,118,835 $120,488 $6,373 $1,689,946
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1662579/000156459021020538/cccc-def14a_20210615.htm

What are C4 Therapeutics, Inc's Past Insider Trades?

C4 Therapeutics, Inc's most recent insider trade came on February 10, 2023 by Utpal Koppikar who bought 5,667 units worth $31.74K . In the last 3 years, insiders at C4 Therapeutics, Inc have sold an estimated value of $16.93M and bought an estimated value of $1.65M worth of shares. Insider trading is most common in February and October, with the busiest year in 2021. The most active traders at the company are Carl Kenneth Anderson, Director,  Malcolm Salter, Director,  and Adam Crystal, Chief Medical Officer .

C4 Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...